Herantis Pharma Plc
Company release 13 May 2026 at 17:35 EEST
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Tone Kvåle
Position: Chief Financial Officer
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 156785/5/5
____________________________________________
Transaction date: 2026-05-13
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: 2026 option rights in Herantis Pharma Plc
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
Transaction details
(1): Volume: 147000 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 147000 Volume weighted average price: 0 EUR
____________________________________________
For more information, please contact:
Tone Kvåle, CFO
Tel: +47 915 19576
Email: ir@herantis.com
Certified Advisor:
UB Corporate Finance Oy, Finland: +358 9 25 380 225
Company website: www.herantis.com